Dual-drug nanotherapy crosses blood–brain barrier, improving survival in preclinical glioblastoma models

Strategic angle: Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, extending survival in preclinical models.